Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) FCF Margin (2021 - 2023)

Senti Biosciences has reported FCF Margin over the past 3 years, most recently at 1540.24% for Q3 2023.

  • For Q3 2023, FCF Margin rose 67652.0% year-over-year to 1540.24%; the TTM value through Jun 2024 reached 9555.33%, down 678698.0%, while the annual FY2025 figure was 198363.64%, N/A changed from the prior year.
  • FCF Margin for Q3 2023 was 1540.24% at Senti Biosciences, up from 2779.18% in the prior quarter.
  • Over five years, FCF Margin peaked at 9182.72% in Q4 2022 and troughed at 2779.18% in Q2 2023.
  • A 3-year average of 210.6% and a median of 1116.96% in 2023 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: soared 974883bps in 2022 and later tumbled -208550bps in 2023.
  • Year by year, FCF Margin stood at 566.11% in 2021, then skyrocketed by 1722bps to 9182.72% in 2022, then crashed by -117bps to 1540.24% in 2023.
  • Business Quant data shows FCF Margin for SNTI at 1540.24% in Q3 2023, 2779.18% in Q2 2023, and 1637.79% in Q1 2023.